We have further sequenced 1,815 blood samples from 1,521 COVID-19 cases with Adaptive TCRβ immunosequencing in order to identify a robust set of SARS-CoV-2 specific CD4 and CD8 TCRs from a fixed number of blood cells (17, 18). The gene discussed is CD8A; the disease is COVID-19.